News & Events 2023
18 Jan 2023
Imperial College London, the world's leading medical education and research institute, has expressed interest in working with Incepta Pharmaceuticals, a renowned vaccine manufacturing of the country. Professor Robin Shattock, head of the research team at the Department of Infectious Diseases, Imperial College, London, visited Vaccine and Injectable plants of Incepta at Savar and Dhamrai . He expressed his great appreciation and said that Incepta’s management is very commendable. Mr. Abdul Muktadir, Chairman and Managing Director of Incepta Pharmaceuticals Ltd., was present during the on-site inspection of vaccine pants. At the end of the visit, mRNA vaccine expert Professor Robin John Shattock reiterated to support Incepta in technology and research to further develop its ability towards a variety of life-saving new vaccines.
Mr Abdul Muktadir, chairman and managing director of Incepta Pharmaceuticals Ltd. stated that Professor Robin John Shattock of Imperial College has helped Incepta to develop protein subunit vaccine in the past. In this continuation, he will also provide technical assistance in the development of other vaccines.
He also added that Incepta is now involved in the development of therapeutic vaccines. We will now jointly research in both replicating and non-replicating mRNA vaccines. We will also participate in future research on mRNA and therapeutic vaccines. He said, Professor Robin is a world-famous scientist. There are many scientists of this country who will be trained with his help and new areas of research will be opened. We have already trained two scientists of Incepta from Imperial College. Many more will be trained soon. This will also open the door to manufacture basic materials (seeds) of vaccine in Bangladesh. We believe that a new era has dawned in the field of research on vaccines and drugs. By doing this it will be possible to bring better benefits to the people.
Jan 09, 2023
Sarah Gilbert, a vaccinologist and co-inventor of AstraZeneca coronavirus vaccine, visited the office of Incepta Pharmaceuticals today.
Gilbert is a professor of vaccine science at the Jenner Institute, Oxford and Nuffield Department of Clinical Medicine of the University of Oxford. She led the development of the Oxford-AstraZeneca vaccine for Covid-19.
She was awarded the prestigious Albert Medal by the Queen in 2021 and Damehood by the Princess Royal at Windsor Castle in 2022 for her contribution to developing the Oxford-AstraZeneca vaccine.
Abdul Muktadir, chairman and managing director of Incepta Pharmaceuticals, and Hasneen Muktadir, vice-chairman, welcomed Gilbert at the Incepta head office in Tejgaon, Dhaka.
Future challenges of vaccine production in Bangladesh, availability of vaccines to common people, and capacity of vaccine production were discussed during her visit. Various aspects of modern and advanced technologies in vaccine production were deliberated and Gilbert gave her guidance on how Incepta can incorporate these modern technologies, said the drug maker.
8 November 2023
Incepta Pharmaceuticals Ltd has been honored with the esteemed 'National Export Trophy' by the Ministry of Commerce, Government of Bangladesh.
The award recognizes the company's outstanding export performance in the fiscal year 2020-2021, highlighting its commitment to quality and trust.
We are moving ahead with a vision to become a trusted Healthcare company to ensure better health for everyone, everywhere.